Biochemical studies of poly-T variants in the Alzheimer's disease associated TOMM40 gene

Journal of Alzheimer's Disease

Volumn 31, Issue 3, 2012, Pages 527-536

  Hedskog, Louise ^a   Brohede, Jesper ^a   Wiehager, Birgitta ^a   Pinho, Catarina Moreira ^b   Revathikumar, Priya ^a   Lilius, Lena ^a   Glaser, Elzbieta ^b   Graff, Caroline ^a,c   Karlström, Helena ^a   Ankarcrona, Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Human fibroblast cell line; late onset Alzheimer's disease (LOAD); mitochondria; TOMM40

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN TOM40; UNCLASSIFIED DRUG;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; TRANSLOCASE OF THE OUTER MITOCHONDRIAL MEMBRANE 40 GENE;

EID: 84865597520     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120580     Document Type: Article

References (33)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. (Pubitemid 23275809)
2. Takei N, Miyashita A, Tsukie T, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kimura H, Kakita A, Takahashi H, Tsuji S, Kanazawa I, Ihara Y, Odani S, Kuwano R (2009) Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics 93, 441-448.
3. Lutz MW, Crenshaw DG, Saunders AM, Roses AD (2010) Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimers Dement 6, 125-131.
4. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM (2010) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 10, 375-384.
5. Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Saykin AJ (2010) Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage 53, 1051-1063.
6. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, Weiner M, Macciardi F (2009) Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 4, e6501.
7. Lutz MW, Crenshaw DG, Saunders AM, Roses AD (2011) The importance of being connected. J Alzheimers Dis 24, 247-251.
8. Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, SagerMA (2011) The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE epsilon3/epsilon3 genotype. Alzheimers Dement 7, 456-465.
9. Chu SH, Roeder K, Ferrell RE, Devlin B, DeMichele-Sweet MA, Kamboh MI, Lopez OL, Sweet RA (2011) TOMM40 poly-T repeat lengths age of onset and psychosis risk in Alzheimer disease. Neurobiol Aging 32, 2328 e2321-e2329.
10. Cruchaga C, Nowotny P, Kauwe JS, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM (2011) Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Arch Neurol 68, 1013-1019.
11. Pomara N, Bruno D, Nierenberg JJ, Sidtis JJ, Martiniuk FT, Mehta PD, Zetterberg H, Blennow K (2011) TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly. Neurochem Res 36, 1124-1128.
12. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21, 3017-3023. (Pubitemid 32323483)
13. Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32, 486-510. (Pubitemid 40591181)
14. Bubber P, Haroutunian V, Fisch G, Blass JP, GibsonGE (2005) Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications. Ann Neurol 57, 695-703. (Pubitemid 40628858)
15. Parker WD Jr, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40, 1302-1303. (Pubitemid 20244999)
16. Parker WD Jr, Parks JK (1995) Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization. Neurology 45, 482-486.
17. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN (1992) Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 59, 776-779.
18. Cardoso SM, Proenca MT, Santos S, Santana I, Oliveira CR (2004) Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 25, 105-110. (Pubitemid 37522198)
19. Hedskog L, Zhang S, Ankarcrona M (2012) Strategic role for mitochondria in Alzheimer's disease and cancer. Antioxid Redox Signal 16, 1476-1491.
20. Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, de Leon MJ (2007) Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 104, 19067-19072.
21. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791. (Pubitemid 35231524)
22. Terry RD (2000) Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 59, 1118-1119. (Pubitemid 32006314)
23. Ingelson M, Vanmechelen E, Lannfelt L (1996) Microtubuleassociated protein tau in human fibroblasts with the Swedish Alzheimer mutation. Neurosci Lett 220, 9-12. (Pubitemid 26423039)
24. Nagasaka Y, Dillner K, Ebise H, Teramoto R, Nakagawa H, Lilius L, Axelman K, Forsell C, Ito A, Winblad B, Kimura T, Graff C (2005) A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings. Proc Natl Acad SciUS A 102, 14854-14859. (Pubitemid 41457145)
25. Weibel E (1979) Stereological methods: Practical methods for biological morphometry, Academic Press, London, 1, 91-100.
26. Zhang S, Hedskog L, Petersen CA, Winblad B, AnkarcronaM (2010) Dimebon (latrepirdine) enhances mitochondrial function and protects neuronal cells from death. J Alzheimers Dis 21, 389-402.
27. Beyer K, Humbert J, Ferrer A, Lao JI, Latorre P, Lopez D, Tolosa E, Ferrer I, ArizaA (2007)Avariable poly-T sequence modulates alpha-synuclein isoform expression and is associated with aging. J Neurosci Res 85, 1538-1546. (Pubitemid 46724397)
28. Hong MG, Alexeyenko A, Lambert JC, Amouyel P, Prince JA (2010) Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease. J Hum Genet 55, 707-709.
29. Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49, 618-632. (Pubitemid 41546661)
30. Bekris LM, Millard SP, Galloway NM, Vuletic S, Albers JJ, Li G, Galasko DR, DeCarli C, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Tsuang D, Peskind ER, Yu CE (2008) Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis 13, 255-266. (Pubitemid 352039030)
31. Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu CE (2010) APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure. Am J Med Genet B Neuropsychiatr Genet 153 B, 409-417.
32. Bekris LM, Lutz F, Yu CE (2012) Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE. J Hum Genet 57, 18-25.
33. Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ (2011) Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology 76, 69-79.